The wire — 11 September 2026

Two strands today, honestly unrelated. First, Paris finally posts — two French rounds from earlier this week that the desk's midweek research did not surface at the time. Second, three rounds from elsewhere in Europe that ran below the wire's coverage threshold in previous editions: Portugal, London, Berlin. No forcing a theme across five companies in four countries; instead, an honest account of what the week produced that hasn't yet been told.

Actionable (Paris) is the largest and the one that most demands scrutiny of its framing. The company — co-founded by Nicolas Rieul, former DG France at Criteo — raises €8.6 million ($10M) in a round led by Hi inov, with Axeleo Capital re-participating. The pitch: an AI platform that maps an enterprise's customer journeys in a proprietary semantic layer and scores every customer daily for churn risk, satisfaction, complaint probability, and repurchase likelihood, with causal explanations. 117 million consumer journeys mapped; 16 enterprise clients including Carrefour, SNCF OUIGO, Engie, and Edenred. The round carries no stage label in any source — ProYarn will not supply one. The use of funds is US expansion and reseller network construction. Whether the causal-scoring model survives contact with US enterprise procurement, where CRM vendors sell prediction as a feature add-on, is the 18-month question.

Hope Care (Portugal) takes the second slot with a €6 million Series A led by Iberis Capital, alongside Vieira de Matos – VDM Capital S.A. and existing investor Buenavista Equity Partners. Hope Care was founded in 2012 — a detail worth sitting with: the company reaching Series A fourteen years after founding suggests either genuine deep-rooted institutional relationships in healthcare procurement (where sales cycles are measured in years) or a domestic market ceiling the European expansion is meant to break. Its OpMA platform integrates medical device data, patient-reported outcomes, and clinical workflows into a single remote patient monitoring view for chronic disease. CEO José Paulo Carvalho: "After more than a decade working with healthcare institutions, we have built a regulated platform that delivers measurable outcomes for patients, healthcare professionals and healthcare systems." European expansion is the stated use; the unstated question is whether the platform's Portuguese regulatory fit translates into procurement in Germany, France, or the UK.

Tellia (Paris) closes a €4.3 million ($5M) pre-seed led by Revent, the Berlin impact VC, with Grey Silo Ventures (Cereal Docks Group's corporate VC arm), Jeriko, and Fund F. Founded in 2024 by Coline Labadie de Faÿ and Vincent Trastour (via Entrepreneur First), Tellia gives farm field teams a voice interface: phone call, WhatsApp, SMS, voice note, or email — anything the worker is already using — and converts those unstructured inputs into structured agronomic records linked to specific parcels, crops, and operations. Reported 80% daily active usage within two months of onboarding. The capital will build an agentic API layer so agricultural software vendors can embed Tellia directly in their own products — the right structural play for a data-capture company that wants to avoid being an app competing on UX.

Veridue (London) closes €3.44 million ($4M) pre-seed led by Episode 1 Ventures — the same firm that backed Ossprey in July — with HTGF and Pi Labs participating. Angels include Cameron Hepburn (Aurora Energy Research co-founder) and Jeremy Palmer (former QuantumBlack CEO). Founded in 2024 by former McKinsey energy advisor Daniel Csonth and ex-SCOR data scientist Xander van den Eelaart, Veridue automates the structured components of due diligence on renewable energy and data centre investments, compressing weeks of consultant work to hours. HTGF's Timo Bertsch: "Capital is ready. Projects are in the pipeline. What's been missing is the ability to move deals at the pace the moment demands." The honest caveat: an investment committee that cannot put a consultant's name on the analysis has different liability exposure than one that can. Whether AI-generated due diligence becomes a standard deliverable or a screening shortcut is still unresolved.

sci2sci (Berlin) closes the day with a €1.2 million pre-seed co-led by Heliad and IBB Ventures, with Robin Capital and Superangels. The company builds AI data verification infrastructure for regulated industries: VectorCat (data cataloguing and lineage tracing for AI outputs) and Integrity (model output verification). Initial target: biopharma, where regulatory submissions must show traceable provenance for every analytical output. The EU AI Act's high-risk category requirements add a compliance deadline that pharmaceutical companies cannot ignore. €1.2M is thin capital for the problem scope; the company's 18-month objective is sufficient deployment depth in biopharma to be structurally embedded before the incumbent compliance vendors close the gap.

France delivered this week — two rounds, both from Paris, both missed by earlier editions this week. The midweek research windows ran before announcement embargoes lifted; the rounds surface here, correctly dated to their announcement.